2021年 主要業績

感染症分野

  • Living-Donor Lung Transplantation for Post-COVID-19 Respiratory Failure. Ohsumi A, Takamatsu J, Yuasa I, Tanaka S, Yutaka Y, Hamaji M, Nakajima D, Yamazaki K, Nagao M, Date H. Ann Thorac Surg. 2021 Nov 5:S0003-4975(21)01840-3.
  • Risk factors of breakthrough aspergillosis in lung transplant recipients receiving itraconazole prophylaxis. Katada Y, Nakagawa S, Nagao M, Yoshida Y, Matsuda Y, Yamamoto Y, Itohara K, Imai S, Yonezawa A, Nakagawa T, Matsubara K, Tanaka S, Nakajima D, Date H, Terada T. J Infect Chemother. 2021 Oct 11:S1341-321X(21)00271-3.
  • Successful treatment of COVID-19-related acute respiratory distress syndrome with a rare blood type: A case report. Yamada H, Ohtsuru S, Nagatomo M, Korogi Y, Shinozuka K, Tanabe N, Kai S, Matsubara T, Ito I, Ihara M, Tanaka T, Kato G, Nagao M, Date H. Clin Case Rep. 2021 Sep 24;9(9):e04859.
  • Oral antibiotic transition in patients with bacteremia with a urinary source due to extended-spectrum β-lactamase-producing Escherichia coli. Noguchi T, Shinohara K, Tsuchido Y, Yukawa S, Yamamoto M, Matsumura Y, Hayashi M, Yamada Y, Hayashi A, Shimizu T, Nagao M. Jpn J Infect Dis. 2021 Aug 31.
  • Three-day regimen of oseltamivir for post-exposure prophylaxis of influenza in hospital wards: a study protocol for a prospective, multi-center, single-arm trial. Ishiguro N, Ito YM, Iwasaki S, Nagao M, Kawamura H, Kanai S, Nukui Y, Tokuda K, Miyara T, Igari H, Yamada K, Chikumi H, Sano C, Koike R, Yagi T, Murakami N; Japan Infection Prevention, Control Conference for National, Public University Hospitals. BMC Infect Dis. 2021 Aug 30;21(1):887.
  • Aging and CMV Infection Affect Pre-existing SARS-CoV-2-Reactive CD8+ T Cells in Unexposed Individuals. Norihide Jo, Rui Zhang, Hideki Ueno, Takuya Yamamoto, Daniela Weiskopf, Miki Nagao, Shinya Yamanaka and Yoko Hamazaki. Published on 10 August 2021 Front. Aging
  • Self-quarantine programme and pre-operative SARS-CoV-2 PCR screening for orthopaedic elective surgery: experience from Japan. Nishitani K, Nagao M, Matsuda S. Int Orthop. 2021 May;45(5):1147-1153.
  • Development of a point-of-care test to detect SARS-CoV-2 from saliva which combines a simple RNA extraction method with colorimetric reverse transcription loop-mediated isothermal amplification detection. Yamazaki W, Matsumura Y, Thongchankaew-Seo U, Yamazaki Y, Nagao M. J Clin Virol. 2021 Mar;136:104760.
  • Possible nosocomial transmission of virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Onda Y, Kanda J, Hanaoka N, Watanabe M, Arai Y, Hishizawa M, Kondo T, Yamashita K, Nagao M, Fujimoto T, Takaori-Kondo A. Ann Hematol. 2021 Mar;100(3):753-761.
  • Comparison of 12 Molecular Detection Assays for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Matsumura Y, Shimizu T, Noguchi T, Nakano S, Yamamoto M, Nagao M. J Mol Diagn. 2021 Feb;23(2):164-170.
  • Comparison of the Xpert Carba-R and NG-Test CARBA5 for the detection of carbapenemases in an IMP-type carbapenemase endemic region in Japan. Kanahashi T, Matsumura Y, Yamamoto M, Tanaka M, Nagao M. J Infect Chemother. 2021 Mar;27(3):503-506.
  • Trends in Population Dynamics of Escherichia coli Sequence Type 131, Calgary, Alberta, Canada, 2006-2016. Peirano G, Lynch T, Matsumura Y, Nobrega D, Finn TJ, DeVinney R, Pitout JDD. Emerg Infect Dis. 2020 Dec;26(12):2907-2915. doi: 10.3201/eid2612.201221.

血液・輸血療法分野

  • Development of a quantitative prediction model for peripheral blood stem cell collection yield in the plerixafor era. Ishii A, Jo T, Arai Y, Oshima S, Kanda J, Kitawaki T, Matsui K, Niwa N, Nakagawa Y, Takaori-Kondo A, Nagao M. Cytotherapy. 2021 Oct 12:S1465-3249(21)00785-4.
  • Azacitidine is a potential therapeutic drug for pyridoxine-refractory female X-linked sideroblastic anemia. Morimoto Y, Chonabayashi K, Kawabata H, Okubo C, Yamasaki-Morita M, Nishikawa M, Narita M, Inagaki A, Nakanishi K, Nagao M, Takaori-Kondo A, Yoshida Y. Blood Adv. 2021 Nov 15.

生理学分野

コメントを残す

メールアドレスが公開されることはありません。 * が付いている欄は必須項目です